Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease
David Darby, Amy Brodtmann, Michael Woodward, Marc Budge, Paul Maruff
International Psychogeriatrics | CAMBRIDGE UNIV PRESS | Published : 2011
Dr Darby and Professor Maruff are employed by CogState Ltd. Acknowledgment of individual funding appears in each published article cited in this paper. No other specific funding was provided to authors to prepare this paper.